Israel was the first country that opted to inoculate the third dose of Pfizer’s vaccine to part of its population. The first people called to receive their prick were immunosuppressed people under 65 years of age And now after a few weeks after the injection, the Sourasky Medical Center in Tel Aviv has been able to Investigate the actual effectiveness of this booster serum.
The study has taken as a sample 240 immunosuppressed patients who have already received this third dose and it has been observed that the Pfizer boost delivers 43% more antibodies than after the second injection. As explained by the research authors, 25% of organ transplant patients had an antibody response to the vaccine after receiving the first and second doses, but after receiving the third that response increased to 50%.
For its part, In the general population under 65 years of age, there was a response rate of 70%, compared to 27% after the second injection. Finally, for those over 65, around 43% developed antibodies, well above the 7% who developed them after the second dose.
The data released by the Tel Aviv center is similar to that published by the Rabin-Beilinson Campus Medical Center in Petah Tikva. “The data is clear proof that the third vaccine works,” Ruthi Rachmimov, director of Beilinson’s department, said after revealing them.
The administration of the reinforcement begins to people over 50 years of age
The Israeli government approved on Friday to vaccinate people over 50 with a third dose, a campaign that will begin this Sunday with more than 50,000 people already registered to inoculate them with the serum. “The third vaccine from 50 years and for medical personnel is effective and correct,” explained Israeli Prime Minister Naftali Bennet.
Israel was one of the countries that vaccinated most of the population faster and with it managed to reduce the rate of infections to a minimum. But nevertheless, the Delta variant has entered the country and has unleashed what for the country is the fourth wave of cases so far in the pandemic, registering about 6,000 new daily positives in the last week. Therefore, the Government accelerates to administer the third dose, a booster that is proving highly effective.
–
